At Premier Research, we focus on doing what we do best: on helping highly innovative pharmaceutical and biotechnology companies bring their life-changing developments from initial strategy through clinical development to regulatory approval. When it comes to orphan drugs and rare diseases we have developed a surprising concentration of experience for a mid-sized CRO. With more than 115 rare disease studies conducted in the past five years, across more than 30 indications, we have become the clinical researcher of choice for sponsors who know they can rely on us to help them navigate the regulations, recruit patients and manage the unique characteristics of smaller trials. It's what we do. Best.